TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN

AC T18332 XX ID T18332 XX DT 24.08.2006 (created); jag. DT 03.01.2014 (updated); spk. CO Copyright (C), QIAGEN. XX FA TLS XX SY D430004D17Rik; D930039C12Rik; FUS; FUS1; fusion, derived from t(12;16) malignant liposarcoma (human); Pigpen protein; RNA-binding protein FUS; TLS. XX OS mouse, Mus musculus OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; rodentia; myomorpha; muridae; murinae XX GE G037215 Fus. XX SF The TLS protein contains a transcriptional activation domain rich in glutamine residues (AD) (aa 1-165), three RGG domains (repeats of the tripeptide Arg-Gly-Gly) (aa 165-246, 372-425, and 454-526) and an 80-amino acid RNA recognition motif (RRM) (aa 287-372), both involved in the binding to RNA. [2]; XX IN T09287 MITF-M; mouse, Mus musculus. IN T01554 MITF; mouse, Mus musculus. IN T13873 MITF; Mammalia. IN T08317 PU.1-xbb1; mouse, Mus musculus. IN T00702 PU.1; mouse, Mus musculus. XX BS R32612. BS R32614. BS R32616. XX DR TRANSPATH: MO000085572. DR UniProtKB: P56959; FUS_MOUSE. XX RN [1]; RE0048819. RX PUBMED: 16785428. RA Bose R., Molina H., Patterson A. S., Bitok J. K., Periaswamy B., Bader J. S., Pandey A., Cole P. A. RT Phosphoproteomic analysis of Her2/neu signaling and inhibition. RL Proc. Natl. Acad. Sci. USA 103:9773-9778 (2006). RN [2]; RE0048122. RX PUBMED: 9478924. RA Hallier M., Lerga A., Barnache S., Tavitian A., Moreau-Gachelin F. RT The transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLS. RL J. Biol. Chem. 273:4838-4842 (1998). XX //